CXCR2 and lung cancer: In addition, Ryan et al. [37] identified a SNP that disrupted a novel binding site for miR-516a-3p, leading to moderate increases in CXCR2 mRNA and protein expression and increased MAPK signaling that was associated with lung cancer risk.